Low-Flow Anesthesia Without Wash-in: Effects on Oxygenation and Depth of Anesthesia
Evaluation of the Safety of Low-Flow Anesthesia Initiated Without Wash-in in Terms of Oxygenation and Depth of Anesthesia Using Arterial Blood Gas Analysis and EEG-Based PSI Monitoring
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to evaluate whether adjusting the fresh gas flow rate to low-flow immediately after intubation, without performing a wash-in, is a reliable approach with respect to depth of anesthesia and oxygenation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 29, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 16, 2026
April 1, 2026
4 months
March 29, 2026
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Comparison of arterial oxygen partial pressure (PaO₂) values between groups
Comparison of arterial oxygen partial pressure (PaO₂) and Patient State Index (PSI) values between groups.
Measured at 10, 20, 30, and 45 minutes after induction of anesthesia and before the end of surgery.
Comparison of Patient State Index (PSI) values between groups.
PSI is an EEG-based index ranging from 0 to 100. Lower values indicate deeper anesthesia; the target range is 25-50 during general anesthesia.
Continuously monitored intraoperatively and recorded at 10, 20, 30, and 45 minutes after induction of anesthesia.
Secondary Outcomes (3)
Mean alveolar concentration (MAC) values
Continuously monitored intraoperatively and recorded at 10, 20, 30, and 45 minutes after induction of anesthesia.
Total sevoflurane consumption
From induction of anesthesia until the end of surgery (average duration approximately X minutes).
Time to reach target MAC level
Time (minutes) from completion of endotracheal intubation to achievement of MAC 1.0, as measured on the anesthesia monitor
Study Arms (2)
Group WI
NO INTERVENTIONIn this group, after intubation, patients were ventilated for 10 minutes with 4 L/min fresh gas flow consisting of 2% sevoflurane and 60% O₂, after which the fresh gas flow rate was reduced to 0.75 L/min
Group WO
ACTIVE COMPARATORIn this group, after intubation, the fresh gas flow rate was set to 0.75 L/min with 60% O₂. The sevoflurane vaporizer was initially set to 8%, and the sevoflurane concentration was subsequently reduced according to the MAC value
Interventions
After endotracheal intubation, fresh gas flow is set to 0.75 L/min with 60% O₂. The sevoflurane vaporizer is initially set to 8%, and the sevoflurane concentration is subsequently titrated according to the target MAC value. Anesthesia depth and oxygenation are monitored using PSI monitoring and serial arterial blood gas measurements.
Eligibility Criteria
You may qualify if:
- ASA physical status I-II
- Cases lasting longer than 30 minutes
- Non-laparoscopic surgical procedures
You may not qualify if:
- Patients with life-threatening renal, cardiac, or hepatic disease
- Patients with chronic pulmonary diseases such as asthma or COPD
- Patients with intraoperative hemodynamic instability
- Patients with a body mass index (BMI) lower than 20 or higher than 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Binali Yildirim Univercity
Erzincan, Erzincan, 24000, Turkey (Türkiye)
Related Publications (7)
Simsek T, Derman S, Kordi RGM, Saracoglu A, Saracoglu KT. The effect of different flow levels and concentrations of sevoflurane during the wash-in phase on volatile agent consumption: a randomized controlled trial. J Clin Monit Comput. 2022 Oct;36(5):1257-1262. doi: 10.1007/s10877-022-00846-w. Epub 2022 Apr 19.
PMID: 35438367BACKGROUNDBahar S, Arslan M, Urfalioglu A, Gisi G, Oksuz G, Bilal B, Oksuz H, Doganer A. Low-flow anaesthesia with a fixed fresh gas flow rate. J Clin Monit Comput. 2019 Feb;33(1):115-121. doi: 10.1007/s10877-018-0135-2. Epub 2018 Mar 23.
PMID: 29572589BACKGROUNDAmirfarzan H, Cassidy KJ, Moaddab M, Demin M, Schumann R, Lewis B. Assessment of seizure duration and utility of using SedLine(R) EEG tracing in veterans undergoing electroconvulsive therapy: a retrospective analysis. J Anesth Analg Crit Care. 2024 Feb 6;4(1):8. doi: 10.1186/s44158-024-00143-9.
PMID: 38321515BACKGROUNDMcIlroy DR, Shotwell MS, Lopez MG, Vaughn MT, Olsen JS, Hennessy C, Wanderer JP, Semler MS, Rice TW, Kheterpal S, Billings FT 4th; Multicenter Perioperative Outcomes Group. Oxygen administration during surgery and postoperative organ injury: observational cohort study. BMJ. 2022 Nov 30;379:e070941. doi: 10.1136/bmj-2022-070941.
PMID: 36450405BACKGROUNDDastan R, Kefeli Celik H, Doganay Z. High, Low, and Minimal Flow Anaesthesia Management: Effects on Oxygen Reserve Index and Arterial Partial Oxygen Pressure. J Coll Physicians Surg Pak. 2023 Nov;33(11):1223-1228. doi: 10.29271/jcpsp.2023.11.1223.
PMID: 37926871BACKGROUNDVarughese S, Ahmed R. Environmental and Occupational Considerations of Anesthesia: A Narrative Review and Update. Anesth Analg. 2021 Oct 1;133(4):826-835. doi: 10.1213/ANE.0000000000005504.
PMID: 33857027BACKGROUNDKutlusoy S, Koca E, Aydin A. Reliability of low-flow anesthesia procedures in patients undergoing laparoscopic cholecystectomy: Their effects on our costs and ecological balance. Niger J Clin Pract. 2022 Nov;25(11):1911-1917. doi: 10.4103/njcp.njcp_387_22.
PMID: 36412300BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 29, 2026
First Posted
April 16, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
PO2, PCO2, PSI, Sevoflurane consumption, Demographic data